Professor Removed from Puberty Blocker Trial Amid Bias Concerns

0:00UK headlines in two minutes or less, you're tuned in to UK News today, brought to you by NordVPN. If you use public Wi-Fi or care about your privacy online, NordVPN helps keep your I-C-D connection secure across all your devices. Links in the episode description. A professor of cardiovascular medicine at the University of Dundee halted a key trial on puberty blockers for children, raising alarms about. Participant ages as young as 10. The Pathways trial, approved months earlier, was paused after his intervention prompted action from health officials. Now, Professor Jacob George has been removed from any further role due to concerns over bias from his personal views. The trial aimed to study blockers on 226 children at a cost of 10.7 million pounds, with recruitment set for January. It stemmed from Baroness Cass's review, which criticized weak evidence for the drugs in treating gender incongruence and called for proper testing. After shutting down a controversial clinic, experts reacted strongly to the news.

1:03A pediatrician argued Georgia's social media posts showed clear personal bias against gender treatments unfit for his public duties. Baroness Cass called the halt bizarre and politically driven, with no new science behind it. Legal advisors noted issues like consent rules for trials, don't rely on child maturity standards. Regulators insists no proven lack of impartiality would step to my side as a precaution. Trial leaders met with the medicines and health care products, regulatory agency twice last week, and plan more talk soon. Some advocates praised Georgia's biology focused stance as mainstream. With meetings ongoing, this pause underscores ongoing debates in child gender care research, as teens push to restart and clarify safety questions.